Business Profile

Business Overview

Procter & Gamble Co. ("P&G") is one of the world's largest fast-moving consumer goods ("FMCG") companies, designing, manufacturing, and marketing a broad portfolio of branded consumer products across personal care, household cleaning, baby care, feminine care, family care, and grooming categories. The company operates through a globally integrated model spanning owned manufacturing facilities, third-party contract manufacturers, and an extensive multi-tier distribution network serving retail, e-commerce, and wholesale channels in approximately 180 countries. P&G is a mature, large-cap enterprise with no ramp-stage characteristics; it competes on brand equity, scale-driven cost efficiency, and sustained R&D investment. Its operational footprint encompasses dozens of manufacturing sites across North America, Europe, Asia-Pacific, Latin America, and the Middle East/Africa, supported by centralized shared-services infrastructure and regional supply chain hubs.

• Legal Name: The Procter & Gamble Company
• Legal Structure: Corporation (State of formation: Ohio; Incorporated: 1905 — successor to partnership established 1837)
• Location: One Procter & Gamble Plaza, Cincinnati, OH 45202 (global headquarters); additional manufacturing, R&D, and administrative sites across approximately 70+ countries
• Established: 1837 (incorporated in Ohio, 1905)
• Founders / Ownership: Founded by William Procter and James Gamble; publicly traded on the New York Stock Exchange (ticker: PG) and NYSE Arca; no single controlling shareholder — broadly held institutional and retail ownership

---

Management

• Jon R. Moeller — Chairman of the Board, President & Chief Executive Officer: Appointed President & CEO in November 2021; Chairman added in January 2022. Previously served as Vice Chairman and CFO. Over 35 years of P&G tenure with deep operational and financial leadership experience across multiple business segments and geographies.
• Andre Schulten — Chief Financial Officer: Appointed CFO in January 2022. Previously held senior finance leadership roles within P&G's Fabric & Home Care and Baby, Feminine & Family Care segments. Responsible for global financial strategy, investor relations, and capital allocation.
• Shailesh Jejurikar — Chief Operating Officer: Appointed COO in October 2021. Oversees global supply chain, manufacturing operations, and go-to-market execution. Prior roles include President of Fabric & Home Care and President of P&G Africa/Eurasia/Middle East.
• Loic Tassel — President, Europe, Middle East & Africa (EMEA): Senior regional executive responsible for P&G's largest international operating region by revenue contribution outside North America.
• Fama Francisco — President, Baby, Feminine & Family Care: Segment president overseeing Pampers, Always, Tampax, Bounty, Charmin, and related brands — one of P&G's highest-revenue business units.
• Board of Directors: 11-member board as of most recent proxy; includes independent directors with backgrounds in consumer goods, technology, finance, and government. Jon Moeller serves as the sole non-independent director.

---

Products & Services / Operations & Capabilities

P&G operates a make-to-stock, branded-goods model across five reportable business segments, with products sold through mass retail, grocery, club, drug, e-commerce, and specialty channels globally. Manufacturing is primarily owned and operated, with selective use of contract manufacturers for capacity flexibility and geographic reach; core formulation, brand management, and R&D remain in-house competencies.

Segment Structure

• Fabric & Home Care: Largest segment by revenue; includes Tide, Ariel, Downy, Gain, Febreze, Mr. Clean, and Swiffer. Encompasses laundry detergents, fabric enhancers, and household cleaners.
• Baby, Feminine & Family Care: Includes Pampers, Luvs, Always, Tampax, Bounty, and Charmin. High-volume, capital-intensive manufacturing with significant private-label competitive pressure in family care.
• Beauty: Includes Pantene, Head & Shoulders, Olay, SK-II, and Old Spice. Mix of mass and prestige positioning; SK-II represents a premium/luxury sub-segment concentrated in Asia-Pacific.
• Grooming: Includes Gillette and Venus razor systems and blades, as well as shave care products. Faces structural volume headwinds from shaving frequency trends; partially offset by premiumization.
• Health Care: Includes Oral-B, Crest, Vicks, Metamucil, Pepto-Bismol, and Neurobion. Straddles OTC healthcare and personal health, with regulatory considerations in certain markets.

Core Operational Capabilities

• Manufacturing footprint: Approximately 100+ owned manufacturing facilities globally as of most recent disclosures; concentrated in North America, Western Europe, and Asia-Pacific.
• R&D infrastructure: Centralized innovation centers in Cincinnati (global HQ), Brussels, Singapore, and Kobe; annual R&D spend consistently in the $1.9–$2.1 billion range.
• Supply chain model: Vertically integrated for core formulation and packaging; third-party logistics providers used for last-mile distribution in select markets.
• Technology & automation: Significant investment in manufacturing automation, digital supply chain platforms, and AI-driven demand forecasting; part of ongoing productivity program targeting multi-billion dollar cost savings over rolling 5-year horizons.
• Sustainability & ESG commitments: Publicly committed to net-zero GHG emissions across Scope 1, 2, and 3 by 2040; recyclable or reusable packaging targets by 2030 — operationally relevant to capital expenditure planning.

Certifications & Regulatory Compliance

• ISO 14001: Environmental management system certification across multiple manufacturing sites globally.
• ISO 9001: Quality management system certification at select manufacturing facilities.
• FDA / OTC Drug Registration: Applicable to Health Care segment products (Crest, Vicks, Pepto-Bismol, Metamucil) sold in the United States; subject to FDA OTC monograph and NDA/ANDA frameworks.
• REACH / EU Cosmetics Regulation: Compliance maintained for Beauty and personal care products distributed in European Union markets.
• Additional certifications: Site-specific certifications vary by facility and product category; full registry detail available via P&G's corporate sustainability and supplier portal disclosures.

---

Markets & Customers

P&G serves the global consumer staples market, with products available in approximately 180 countries and territories. North America (primarily the United States) represents the largest single geographic revenue contributor, accounting for approximately 45–47% of net sales in recent fiscal years, with Europe and Asia-Pacific each contributing materially to the balance. The company's end-market exposure is characterized by non-discretionary, daily-use consumption patterns, providing structural demand stability across economic cycles — a credit-positive attribute.

• Customer concentration — Walmart: Walmart Inc. (including Sam's Club) is P&G's largest single customer, publicly disclosed as representing approximately 15% of consolidated net sales in recent annual filings (10-K). This represents meaningful single-customer concentration; however, the relationship is long-standing, multi-category, and mutually strategic.
• Broader retail channel: No other individual customer has been publicly disclosed as exceeding 10% of net sales. The remainder of the customer base is broadly distributed across mass retail (Target, Costco, Carrefour, Tesco), grocery chains, drug retail (CVS, Walgreens), e-commerce platforms (Amazon), and international distributors.
• E-commerce: Direct-to-consumer and e-commerce channels represent a growing share of revenue; P&G has disclosed e-commerce as a double-digit percentage of global sales in recent periods, with continued investment in digital shelf and direct channels.
• Geographic diversification: Presence across developed and emerging markets provides revenue diversification; however, currency translation risk and geopolitical exposure (particularly in Russia/Ukraine, Middle East, and select emerging markets) represent ongoing credit considerations.
• B2B / Institutional: P&G Professional segment serves away-from-home and institutional channels (hospitality, foodservice, healthcare facilities) with commercial-grade versions of core brands — a smaller but margin-accretive revenue stream.

---

Source Note

Key company facts validated via Ohio Secretary of State filings, SEC EDGAR (Form 10-K, DEF 14A proxy statements), official company website (us.pg.com), and P&G investor relations disclosures as of June 2025.

Financial Analysis

Procter & Gamble demonstrates a high-quality, investment-grade credit profile characterized by stable revenue generation, expanding margins, conservative leverage (~1.8x Net Debt/EBITDA), and robust free cash flow coverage of debt obligations across the FY2023–FY2025 review period.

Income Statement Analysis

• Revenue growth decelerating but stable: Total revenues grew +2.5% YoY in FY2024 ($84.0B) and moderated to +0.3% in FY2025 ($84.3B), reflecting a mature, near-saturation top-line profile consistent with a large-cap consumer staples issuer.
  • Three-year revenue base remains anchored above $82B, providing a predictable earnings floor.
  • Low single-digit growth reflects pricing normalization following post-pandemic volume recovery rather than structural demand deterioration.
• Gross margin expansion is material and sustained: Gross margin improved from 47.9% (FY2023) to 51.4% (FY2024) and held at 51.2% (FY2025), a ~330bps structural improvement.
  • Expansion driven by favorable input cost trends and pricing carryover; FY2025 stability confirms margin durability rather than one-time benefit.
• EBITDA margin inflected sharply in FY2025: EBITDA margin expanded from 19.6% (FY2024) to 22.4% (FY2025), with absolute EBITDA increasing to $18.9B (+$2.4B YoY).
  • FY2023–FY2024 EBITDA was essentially flat ($16.4B vs. $16.5B); FY2025 step-up suggests operating leverage realization or below-the-gross-profit cost discipline.
  • Operating margin similarly expanded to 24.3% in FY2025 vs. ~22.1% in FY2023–FY2024.
• Net income trajectory is positive: Net income grew from $14.5B (FY2023) to $16.3B (FY2025), with net margin expanding from 17.7% to 19.4%, reflecting both operational improvement and stable below-the-line items.

Balance Sheet Analysis

• Leverage is low and improving: Total Debt/EBITDA declined from 1.97x (FY2024) to 1.82x (FY2025), well within investment-grade thresholds; debt increase of ~$2.0B was more than offset by EBITDA growth.
  • Total debt increased modestly from $32.5B to $34.5B, consistent with routine refinancing or working capital facility utilization.
• Capital structure is conservatively positioned: Debt/Capital ratio of ~39.8% (FY2025) and Debt/Assets of ~27.6% reflect a balance sheet with significant equity cushion ($52.3B equity base).
  • Debt/Equity of 0.66x is modest for a company of P&G's scale and cash generation capacity.
• Asset base is growing: Total assets increased from $122.4B (FY2024) to $125.2B (FY2025), driven in part by PP&E growth ($22.2B to $23.9B), consistent with ongoing capital investment.
  • Equity grew from $50.6B to $52.3B, indicating retained earnings accretion net of shareholder returns.
• No operating lease adjustment required: Operating lease-adjusted debt equals reported debt in both periods, indicating minimal off-balance-sheet lease exposure relative to total obligations.

Cash Flow Analysis

• CFO is strong but showed FY2025 normalization: Operating cash flow declined from $19.8B (FY2024) to $17.8B (FY2025), following an elevated FY2024 that likely benefited from working capital timing; FY2025 CFO remains well above FY2023 ($16.8B).
  • CFO/Total Debt of 0.52x in FY2025 (vs. 0.61x in FY2024) remains strong in absolute terms.
• CapEx is rising but manageable: Capital expenditures increased from $3.1B (FY2023) to $3.8B (FY2025), representing ~4.5% of revenue — consistent with maintenance and modest capacity investment for a consumer goods platform.
  • CapEx/CFO ratio of ~21% in FY2025 leaves substantial residual cash flow for debt service and distributions.
• FCF generation is robust: FCF of $14.0B in FY2025 (vs. $16.5B in FY2024) reflects the CFO normalization; FCF/Total Debt of 0.41x provides meaningful debt repayment capacity.
  • Three-year average FCF of ~$14.8B underscores the consistency of cash generation across the cycle.
• FFO improved materially in FY2025: FFO increased to $13.5B in FY2025 from $11.2B in FY2024, driven by EBITDA expansion; FFO/Total Debt of 0.39x is consistent with a low-investment-grade to high-yield boundary — well above P&G's actual credit profile.
  • Financing outflows of ~$14.0B in FY2025 reflect ongoing shareholder returns (dividends + buybacks), a structural use of cash for this issuer.

Working Capital Analysis

• Negative CCC is a structural credit positive: P&G operates with a deeply negative cash conversion cycle of approximately -57 days (FY2024) and -56 days (FY2025), meaning the business self-funds through supplier financing.
  • DPO of ~113 days in both periods reflects P&G's dominant purchasing leverage over suppliers — a durable structural advantage.
• Receivables and inventory turns are efficient: DSO of ~26 days and DIO of ~30–31 days are consistent with a consumer staples business selling through large retail channels with short collection cycles.
  • DIO increased marginally (+1.1 days YoY) in FY2025, not material at current scale.
• Working Capital Requirement (WCR) is structurally negative: WCR of -$12.8B (FY2025) confirms that P&G collects cash before paying suppliers — a net source of liquidity rather than a use.
  • Negative WC of -$10.7B (FY2025) is not a liquidity concern given the business model; it reflects the payables-funded operating cycle.

Liquidity Analysis

• Headline liquidity ratios are below 1.0x but not a concern: Current ratio of 0.70x and quick ratio of 0.49x in FY2025 reflect the structural negative working capital model; these ratios are expected and appropriate for P&G's business profile.
  • Comparison to peers in consumer staples confirms sub-1.0x current ratios are sector-normal for companies with dominant payables leverage.
• Cash position is adequate: Cash & equivalents of $9.6B (FY2025) provide a meaningful near-term liquidity buffer against the $9.5B CPLTD balance — near 1:1 coverage on a spot basis.
  • CPLTD increased from $7.2B (FY2024) to $9.5B (FY2025), representing the primary near-term refinancing risk; manageable given access to capital markets and $13.5B FFO.
• Operating CF Ratio declined but remains adequate: CFO/Current Liabilities of 0.49x (FY2025) vs. 0.59x (FY2024) reflects both the CFO normalization and the increase in current liabilities; annual FFO of $13.5B provides ample coverage.
  • Undrawn credit facility data is not available in the provided dataset; confirmed availability would further strengthen the liquidity assessment.
• Interest coverage is strong: EBITDA/Interest Expense of ~20.9x (FY2025) and EBIT/IE of ~22.5x confirm minimal debt service burden relative to earnings generation.

Debt & Coverage Analysis

• Interest coverage is very strong across all metrics: EBITDA/IE of 20.9x (FY2025) and EBIT/IE of 22.5x reflect a company where interest expense ($907M) is de minimis relative to operating earnings ($20.5B).
  • Coverage ratios are directionally consistent across FY2023–FY2025, with no deterioration trend.
  • Note: EBIT/IE and EBITDA/IE are presented as negative values in the source data, indicating interest expense is recorded as a negative figure; absolute coverage multiples are referenced here.
• EBITDA/(IE + CPLTD) tightened in FY2025: This blended debt service coverage metric declined from 2.63x (FY2024) to 2.20x (FY2025), driven by the $2.3B increase in CPLTD.
  • 2.20x remains a comfortable coverage level; the decline is a function of debt maturity scheduling rather than earnings deterioration.
• Leverage trajectory is improving: Net Debt/EBITDA declined from 1.97x (FY2024) to 1.82x (FY2025), consistent with EBITDA growth outpacing incremental debt issuance.
  • At current FCF generation rates, P&G could theoretically retire all outstanding debt within approximately 2.5 years — a theoretical measure of balance sheet strength.
• Financing outflows reflect shareholder return priority: CF Financing of -$14.0B (FY2025) indicates that substantially all FCF is returned to shareholders via dividends and buybacks, consistent with P&G's capital allocation policy; this is a structural feature, not a credit risk at current leverage levels.

CapEx Analysis

• PP&E base is growing steadily: Net PP&E increased from $22.2B (FY2024) to $23.9B (FY2025), a $1.7B net increase, consistent with reported CapEx of $3.8B less estimated depreciation.
  • Implied depreciation of approximately $2.0–$2.1B (derived from PP&E roll) is consistent with a capital-light consumer goods manufacturing model.
• CapEx intensity is moderate and rising: Reported CapEx increased from $3.1B (FY2023) to $3.8B (FY2025), a ~23% increase over two years, suggesting capacity investment or manufacturing modernization.
  • CapEx as a percentage of revenue: ~3.7% (FY2023), ~4.0% (FY2024), ~4.5% (FY2025) — trending upward but well within FCF generation capacity.
• CapEx Estimate (PP&E-derived) is not computable for FY2024: Beginning PP&E for FY2024 is not available in the dataset; the FY2025 estimate is derivable from the FY2024–FY2025 PP&E roll. Reported CapEx figures are used as the primary reference.

Data Notes & Limitations

• FY2023 balance sheet data unavailable: Total Debt, Total Assets, Total Equity, and all derived leverage/liquidity ratios for FY2023 are not present in the dataset; trend analysis for balance sheet metrics is limited to FY2024–FY2025.
• Undrawn credit facility not provided: Revolving credit facility availability is not included; total liquidity may be materially understated. P&G is known to maintain significant committed credit lines; confirmation from public filings is recommended.
• CapEx Estimate (PP&E-derived) incomplete: Beginning PP&E for FY2024 and depreciation figures for both periods are absent; the PP&E-based CapEx estimate cannot be computed. Reported CapEx from the cash flow statement is used throughout.
• Interest coverage sign convention: EBIT/IE and EBITDA/IE are presented as negative values in the source data, consistent with interest expense being recorded as a negative line item; all coverage multiples in this memo are expressed in absolute terms.
• Operating lease adjustment is nil: EBITDA (Op. Lease Adj.) equals reported EBITDA in all periods, and Total Debt (incl. Op. Leases) equals reported Total Debt; either operating leases are immaterial or are already capitalized in the reported figures. Verification against footnote disclosures is recommended.
• Fiscal year convention: P&G's fiscal year ends June 30; FY2025 refers to the year ended June 30, 2025. All figures sourced from publicly reported financial statements.